Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Biochim Biophys Acta. 2011 Aug 10;1810(12):1285–1293. doi: 10.1016/j.bbagen.2011.07.018

Table 2. Biophysical Variables of A341V Constructs: Heterozygous Clinical Situation (A341V+KCNQ1+KCNE1) and Corresponding Wild Type IKs (2KCNQ1+KCNE1).

A341V+KCNQ1+KCNE1 2KCNQ1+KCNE1
V0.5, mV 30.2 ± 1.2 * 23.3 ± 1.7
k 12.2 ± 0.5 14.6 ± 0.7
T0.5, ms 514 ± 55 * 263 ± 30
τf, ms 197 ± 9 219 ± 19
τs, ms 729 ± 74 * 2095 ± 239
n 12 11

V0.5 = voltage of half-maximal activation; k = slope factor; T0.5 = activation time to half-maximal amplitude at +60 mV; τf = fast time constant; τs = slow time constant; n = number of experiments

V0.5, k, T0.5, τf and τs were determined as described in Methods. Data are presented as mean ± SE.

*

P < 0.01 versus 2KCNQ1+KCNE1,

P < 0.05 versus 2KCNQ1+KCNE1